Screener
Eligibility screening
EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
39 US sites in AL, AZ, CA, CO +15
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
39 US sites in AL, AZ, CA, CO +15
Before we begin
Your answer affects how the questions are phrased.